Background {#Sec1}
==========

Hypertension (HTN) remains a public health challenge worldwide because of its high prevalence and related complications. In 2000, 26.4 % of the World's adult population had hypertension \[[@CR1]\]. In Sub-Saharan Africa (SSA), the prevalence of HTN varied from 6 to 48 % \[[@CR2]\]. In the Democratic Republic of Congo (DRC), the prevalence of HTN has been increasing for the past three decades. In 1987, the prevalence was 14.2 % in urban and 9.9 % in rural areas \[[@CR3]\] and almost doubled in 2005 to reach 26.7 % \[[@CR4]\].

In SSA, the control of HTN is low. For example, in West African countries this control is low, less than 10 % except for Nigeria where it is approximately 30 % \[[@CR5]\]. In the DRC, the Vitaraa study conducted in Southern Kivu found that 86.4 % of hypertensive patients were uncontrolled \[[@CR6]\]. Uncontrolled HTN is one of the main cardiovascular risk factors (CVRF) \[[@CR7]\] and based on the World Health Organization (WHO) estimates, at least 50 % of cardiovascular diseases (CVD) and 75 % of strokes are consequences of high blood pressure \[[@CR8]\]. In the DRC, HTN-related complications including stroke, chronic kidney disease (CKD) are increasingly reported \[[@CR9]--[@CR11]\].

Non-adherence to antihypertensive medication (NAM) is one of the main factors contributing to uncontrolled HTN \[[@CR12]\]. In fact, benefits of antihypertensive medication to decrease cardiovascular complications have been established. However, inadequate adherence to antihypertensive therapy or NAM has been linked to the development of cardiovascular complications. The NAM is described as a widespread problem in an insidious chronic condition like HTN \[[@CR13]\] and studies have shown that populations of African descent with HTN were less adherent to medication compared with Caucasians. The overall prevalence of medication adherence in this population was lower for any definition used \[[@CR14]\]. NAM is also associated with cardiovascular mortality risk. A cohort study conducted in Brazil reported that the risk of mortality from CVD was three times higher in patients discontinuing HTN medication compared with those who regularly took their medication \[[@CR15]\]. Thus, given the situation described previously for the DRC, we believe that it is essential to identify and gain a better understanding of the factors associated with NAM in our settings with the overreaching goal to inform strategies for improving patient adherence to medication. Therefore, using the WHO framework that describes five dimensions of factors that may affect adherence to therapy and the Morisky Medication Scale, a validated self-reported medication scale, this study aims to measure non-adherence to antihypertensive medication and to identify its predictors.

Methods {#Sec2}
=======

Design {#Sec3}
------

From October 2013 to November 2013, a cross-sectional study was carried out at Kinshasa Primary Health-care (KPHC) network facilities. This network consists of 51 facilities that allows for follow-up of patients with NCDs like hypertension and diabetes, living in Kinshasa \[[@CR16]\].

Study population {#Sec4}
----------------

### Inclusion criteria {#Sec5}

We included in the study hypertensive patients \>18 years who have been under antihypertensive drugs for at least a month.

### Exclusion criteria {#Sec6}

Hypertensive pregnant women were excluded.

Sampling {#Sec7}
--------

Only 25, out of 51 facilities, scheduled patients' visits during the survey were therefore selected. All patients present in the facility and who met the inclusion criteria were enrolled. The sample size was computed using the following formula $\documentclass[12pt]{minimal}
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                \begin{document}$$n \ge \frac{{Z_{\alpha }^{2} \cdot p \cdot q}}{{d^{2} }}$$\end{document}$ where the **p** represents the proportion of non-adherence to antihypertensive medication (we assumed that p = 50 % because the proportion of NAM in the DRC is unknown), **q** (1 − p), **z** value of the standard normal distribution corresponding to a significance level of alpha of 0.05 (1.96) and **d** the precision degree that we assumed to 5 % too. The minimal size computed was 384 patients. A total of 408 patients present in the health facilities were selected but only 395 (96.8 %) were eligible and enrolled. The study protocol was approved by the institutional review boards of the Kinshasa School of Public Health, Bureau Diocésain des Oeuvres Médicales de Kinshasa, and Service Médical Armée du Salut and conducted in accordance with the Helsinki Declaration II. All study participants provided written informed consent.

Data collection and study variables {#Sec8}
-----------------------------------

Patients were surveyed using a structured questionnaire, either in French or translated in Lingala, the local language. Five surveyors had been trained over 3 days and the interview instrument was pretested prior to its use. Covariates were defined according to the WHO framework. This framework was used because actually, no model of medication adherence for HTN has been published. The Health Beliefs Model has been used in several studies but it does not include all the dimensions of the NAM factors like those described by the WHO framework \[[@CR17]\]. The variables collected entailed social and economic characteristics of patients (gender, age, marital status, religious affiliation, education, employment); conditions-related variables (duration of HTN, control of blood pressure, experience of physical symptoms due to HTN, co-morbidity); therapy-related variables (duration of antihypertensive medication treatment, number of pills taken daily, experience of medication side effects, use of non-prescribed medication, treatment adherence); patients-related variables (knowledge of HTN risk factors and complications, knowledge of treatment benefit, perception of hypertension gravity and hypertension-related complications gravity, beliefs on BP medications importance, status acceptation); healthcare team and system-related variables (patient--provider relationship, patient education, perception of treatment cost, geographical accessibility, availability of antihypertensive drugs).

Co-morbidity has been defined in this study as HTN associated with diabetes mellitus (DM) or organ damage targets (heart disease, strokes, or CKD). Patients were interviewed if identified by a health professional as having one of these conditions.

Only the blood pressure measured by healthcare providers on the day of the survey and recorded in the patient medical file was considered. Three hundred ninety (390) out of three hundred ninety five (395) had the values of blood pressure recorded in their medical file (98.7 %). Uncontrolled HTN was defined, for a patient without co-morbidity, as a patient with a SBP ≥140 mmHg and a DBP ≥90 mmHg. For a patient with co-morbidity, uncontrolled HTN was defined as a patient with SBP ≥130 mmHg and for DBP ≥80 mmHg \[[@CR18]\].

The self-reported medication adherence was measured using the Morisky Scale, which is a validated scale with a good internal consistency. Its Cronbach's alpha has been reported to be of 0.90 in studies of inner-city patients with hypertension \[[@CR19], [@CR20]\]. Patients responded, "yes" or "no" to the four questions and have been categorized into three groups, namely high, medium and low adherence, as summarized in Table [1](#Tab1){ref-type="table"} \[[@CR19]\]. Thereafter, adherence was dichotomized in order to facilitate statistical analysis. The low and medium adherence was merged and classified as non-adherent and patients with high adherence were classified as adherent, like previously used by Patel \[[@CR21]\].Table 1Morisky ScaleHigh adherence, if the sum = 0; medium adherence, if the sum is comprised between 1 and 2 and low adherence if the sum is comprised between 3 and 4Have you ever forgotten to take your BP medicine?0. No1. YesAre you sometimes careless in regard to your medicine?0. No1. YesDo you skip your medicine when you are feeling well?0. No1. YesWhen you feel bad due to the medicine, do you skip it?0. No1. YesSource: Morisky et al. \[[@CR19]\]

Statistical analysis {#Sec9}
--------------------

All analyses were performed using Statistical Package for Social Sciences (SPSS) version 21.0. (SPSS, Inc., Chicago, IL, USA). Descriptive statistics were used to summarize the study population characteristics. Continuous variables were reported using mean with standard deviation. Means for age of non-adherent and adherent patients were compared using Student's *t* test. Categorical variables were reported as a frequency and percentage and groups were compared using χ^2^ test. The logistic regression helped to identify independent predictors of non-adherence. All variables associated with non-adherence to antihypertensive medication in the bivariate analysis were included in the final model. Odds ratio (OR) with a corresponding 95 % confidence interval was reported to quantify the strength of association. Significance was set at p-value of less than 0.05.

Results {#Sec10}
=======

Patients' socioeconomic and clinical characteristics {#Sec11}
----------------------------------------------------

Tables [2](#Tab2){ref-type="table"} and [3](#Tab3){ref-type="table"} summarize socio-economic and clinical characteristics of the patients. A total of 395 patients were assessed. The mean age of participants was 63.3 ± 9.6 years and nearly 76 % were female; almost half were married (45.6 %) and Catholic Christians (48.9 %); 40.5 % completed at least secondary school and 63.5 % were unemployed.Table 2Socio-economic characteristics of hypertensive patients, Kinshasa, 2013 (n = 395)Variablesn%Mean (SD), age63.3 ± 9.6 yearsFemale gender30075.9Marital status Currently married18045.6 Widowed17845.1 Divorced/separated246.1 Never married133.3Religious affiliation Catholic Christians19348.9 Protestant Christians7318.5 Pentecostal Christians6115.4 Kimbanguist Christians246.1 Other religious affiliations4411.1Education No formal8220.8 Primary15338.7 Secondary12631.9 Tertiary348.6Employment Unemployed/retired17444.0 Employed14436.5 Housewife7719.5Table 3Clinical characteristics of hypertensive patients, Kinshasa, 2013 (n = 395)Variablesn(%)Duration of hypertension, year \<522055.7 ≥514936.7 Unknown266.6Duration of antihypertensive treatment, year \<523960.5 ≥512631.9 Unknown307.6Control of blood pressure, n = 390 Uncontrolled32984.4 Controlled6115.6Number of pills, n = 395 Mean (SD)1.7 (1.2)Experience of medication side effects21754.9Experience of physical symptoms due to hypertension25564.6Physical symptoms felt, n = 255 Dizziness15761.6 Tiredness8432.9 Blurred vision7930.9 Headache6023.5 Palpitations176.6 Additional symptoms207.8Presence of co-morbidity21353.9Types of co-morbidityDiabetes20752.4Heart diseases61.5Taking of non-prescribed medications8120.5Adherence measurement Have you ever forgotten to take your BP medicine?12631.9 Are you sometimes careless in regard to your medicine?8423.8 Do you skip your medicine when you are feeling well?12431.4 When you feel bad due to the medicine, do you skip it?8722.0Medication non-adherence21454.2

Approximately half of the patients suffered from HTN for less than 5 years. The mean systolic blood pressure was 148.6 ± 22.1 and 87.8 ± 14.3 mmHg for the diastolic blood pressure. The control of HTN was present in 15.6 % (95 % CI 12.1--20.0 %) patients. Almost two-thirds of the patients (64.6 %) experienced physical symptoms due to HTN. Dizziness was the most common physical symptom reported. Co-morbidities were present in 53.9 % of participants, of which DM was the most common (52.4 %).

More than half of the participants had less than 5 years of antihypertensive treatment duration. On average, the patients took 1.7 ± 1.2 pills daily. Approximately half of the patients (55.9 %) experienced medication side effects, 20.5 % declared taking non-prescribed medications. Around one in three patients reported to have forgotten to take blood pressure medicine (31.9 %) and to have skipped taking drugs when they felt well (31.4 %). Using the Morisky Scale, we found that over half of participants (54.2 %) were non-adherent to their medication.

Patients' knowledge, beliefs and perception {#Sec12}
-------------------------------------------

Table [4](#Tab4){ref-type="table"} summarizes the study of the population knowledge, beliefs and perception about HTN and its treatment. Poor knowledge of the risk factors related to lifestyle was observed. Stress/anxiety was the most frequent risk factors mentioned (67.6 %) and stroke was the most common complication mentioned (37.2 %). The control of blood pressure was the most common mentioned benefit of antihypertensive treatment (55.4 %), the majority of patients believed in the importance of blood pressure medication in controlling BP (86.3 %) and accepted their hypertensive status (85.6 %). Also, the majority of the patients in this study thought it possible to adhere to treatment (92.4 %).Table 4Knowledge and perception of hypertensive patients, Kinshasa, 2013 (n = 395)Variablesn(%)Risk factors related to HTN mentioned Anxiety/stress26767.6 Do not know6115.4 Salt intake/unhealth diet256.3 Alcohol intake194.8 Other factors287.1Hypertension-related complications mentioned Stroke14737.2 Death11027.8 Heart diseases225.6 Diabetes143.5 Others184.6Knowledge of treatment benefit Control of BP21955.4 Decrease the risk of complications10526.6 Decrease the risk of mortality4611.6 Do not know246.1 Healing194.8Beliefs that BP medications are helpful in controlling BP Very helpful/helpful34186.3 Somewhat helpful/not helpful4511.4 Do not know102.3Status acceptation33885.6Self-perception of ability to adhere to treatment36592.4

Health team and health system variables {#Sec13}
---------------------------------------

Table [5](#Tab5){ref-type="table"} summarizes the health team and system variables and shows that almost all patients declared that their relationship with care providers was very good or good (94.7 %). More than half of the patients reported that their health facility provided hypertensive patients with education (65.1 %); 86.3 % declared they payed for treatment. Three-quarters of the patients thought that the cost of the treatment was inexpensive (73.3 %). The majority of the patients reported that antihypertensive drugs were available in the healthcare facility when they needed them (87.1 %). The healthcare facilities were for the most part accessible geographically (74.2 %).Table 5Health team and system related factorsPerception of patient-provider relationshipsn%Very good/good37494.7Somewhat good/bad215.3Patient education performed in the healthcare facility25765.1Have paid for treatment34186.3Perception of treatment cost, n = 341 Very inexpensive/inexpensive25073.3 Very expensive/expensive247.0 Do not know6719.6Healthcare facility accessible geographically29374.2Availability of antihypertensive medications in the healthcare facilities34387.0

Predictors of non-adherence to antihypertensive treatment {#Sec14}
---------------------------------------------------------

Table [6](#Tab6){ref-type="table"} summarizes the predictors of NAM after logistic regression. Poor knowledge about complications of hypertension (OR = 2.4; 95 % CI 1.4--4.4); unavailability of antihypertensive drugs in the healthcare facilities (OR = 2.8; 95 % CI 1.4--5.5), lack of hypertensive patients education in the healthcare facilities (OR = 1.7; 95 % CI 1.1--2.7), prior experience of medication side effects (OR = 2.2; 95 % CI 1.4--3.3), uncontrolled blood pressure (OR = 2.0; 95 % CI 1.1--3.9) and taking of non-prescribed medications (OR = 2.2; 95 % CI 1.2--3.8) were independently associated with NAM in this study.Table 6Bivariate and multivariate analysis determinants of non-adherence to antihypertensive medicationVariablesBivariate analysisMultivariate analysisCrude OR (95 % CI)P valueAdjusted OR (95 % CI)P valueAge0.782----Gender0.8 (0.5--1.3)0.412----Education No formal1.0 (0.5--2.3)0.921---- Primary1.9 (0.9--4.2)0.078---- Secondary1.5 (0.7--3.3)0.272---- TertiaryOccupation Unemployed/retired0.9 (0.6--1.4)0.832---- EmployedDuration of hypertension, year Unknown0.6 (0.3--1.5)0.317---- ≥51.3 (0.8--1.9)0.284---- \<5Duration of antihypertensive treatment, year Unknown0.9 (0.4--1.9)0.897---- ≥51.2 (0.8--1.9)0.342---- \<5Control of blood pressure n = 390 Uncontrolled1.8 (1.1--3.2)0.032\*2.0 (1.1--3.7)0.018\*Experience of medication side effects1.9 (1.3--2.9)0.001\*2.2 (1.4--3.3)0.001\*Experience of physical symptoms due to hypertension1.4 (0.9--2.1)0.122----Presence of Co-morbidity1.2 (0.8--1.7)0.465----Taking of non-prescribed medications1.7 (1.1--2.8)0.042\*2.2 (1.2--3.8)0.006\*Poor knowledge of risk factors related to HTN0.7 (0.5--1.1)0.140----Poor knowledge of HTN related complications2.5 (1.4--4.3)0.001\*2.4 (1.4--4.4)0.003\*Poor knowledge of treatment benefit1.5 (0.7--3.1)0.324----Beliefs that BP medications are helpful in controlling BP1.3 (0.7--2.3)0.421----Accept hypertensive status1.2 (0.7--2.0)0.589----Perception of HTN gravity1.1 (0.6--1.8)0.838----Perception of HTN related complications gravity1.2 (0.7--2.0)0.526----Perception of patient-provider relationships2.0 (0.8--4.9)0.128----Lack of patient education performed in the healthcare facility1.9 (1.3--2.9)0.003\*1.7 (1.1--2.7)0.023\*Perception of treatment cost0.9 (0.6--1.6)0.948----Healthcare facility accessible geographically0.9 (0.6--1.5)0.771----Unavailability of antihypertensive medications in the healthcare facilities2.6 (1.3--5.2)0.003\*2.8 (1.4--5.5)0.003\*\* p value \<0.05

Discussion {#Sec15}
==========

This study aimed to measure NAM and to identify its predictors. This study found a high prevalence of NAM and a poor control of blood pressure. Patients, therapy and health system factors were the predictors of NAM.

The prevalence of non-adherence to antihypertensive medication was high and consistent with previous findings \[[@CR14], [@CR22], [@CR23]\]. However, this prevalence could have been underestimated because of two factors: age of the patients and level of the facilities surveyed. The mean age of patients in this study was 63.3 ± 9.6 years whereas a previous study conducted in the DRC reported a mean age of 54.3 ± 9.2 years among patients admitted to hospital for HTN-related complications \[[@CR11]\]. Previous studies reported that, compared with older patients, younger patients were more likely to be non-adherent \[[@CR24], [@CR25]\]. Then, we posed a question on the follow-up of the younger hypertensive patients. Probably, younger hypertensive patients in Kinshasa are underdiagnosed. The Vitaraa Study conducted in Southern Kivu province of the DRC reported that more than half of the hypertensive patients were unaware of their status \[[@CR6]\]. Given that older patients usually have several health concerns, the probability of HTN being diagnosed incidentally is high. Secondly, this study was carried out in primary healthcare facilities that use essential or generic drugs, which were inexpensive. The cost of drugs is described as a factor of non-adherence; it has been minimized in this study. Also, some non-adherent patients may have developed complications necessitating hospital admission at secondary and tertiary facilities. Overall, we believe that if this study was carried out at secondary and tertiary levels, the proportion of non-adherence would have been higher.

This study also reported a poor control of blood pressure. These findings corroborate previous studies carried out in African populations, where the proportion of blood pressure control was very low, less than 10 % \[[@CR5]\]. This poor control may be explained partly by the presence of patients with co-morbidity at primary-level care facilities. Co-morbidity has been defined in this study as HTN associated with diabetes or organ damage targets. Hypertensive patients associated with these diseases are categorized as high cardiovascular risk and this category of patients cannot be followed at the primary-level care facilities \[[@CR18]\]. The low proportion of blood pressure control reported in this study could explain the prevalence of HTN-related complications reported at secondary and tertiary levels care in the DRC.

This study reports poor knowledge about risk factors related to HTN. This has also been described by a previous study carried out in Pakistan \[[@CR26]\]. Furthermore, stress is the main factor, as corroborated by a study carried out in Zimbabwe where 70.6 % of patients mentioned stress as a cause of hypertension \[[@CR27]\]. However, risk factors related to lifestyle such as obesity, tobacco use and excessive alcohol consumption were not often mentioned. In this study, stroke has been the most mentioned as a complication of HTN in contrast with a study conducted in Pakistan, where the heart complication was the most mentioned (30.6 %) \[[@CR24]\]. This difference may be explained by the fact that stroke has been described as a major CVD present in the black population \[[@CR18]\].

Social and economic factors (education level, sex, age, employment) are described by the WHO as the NAM factors \[[@CR14]\]. In this study none of these factors have been associated with NAM. We provided some explanations above on age and employment, the latter has not been associated with NAM, probably because the majority of patients declared that antihypertensive drugs were inexpensive.

Hypertension is considered as a condition without symptom, the experience of physical symptoms due to HTN influences treatment adherence significantly, patients who do not feel unwell may be less adherent. In a qualitative study carried out in Bandundu (a province of the DRC), hypertensive patients reported that they took medication only when they experienced perceived symptoms of HTN \[[@CR28]\]. In this study, no association was found between patients experiencing physical symptoms and treatment adherence. This result is consistent with a previous study which did not find this association \[[@CR29]\].

Patient education is described as a catalyst for lifestyle change and treatment adherence \[[@CR27]\]. This association with treatment adherence has previously been reported \[[@CR30]\]. Patient education improves the patient's understanding of diseases, lifestyle change and medication. In this study, patients who admitted to benefitting from education and who had a good knowledge of hypertension and its complications respectively were twice more likely to be treatment adherent.

Also, this study found that patients who took non-prescribed medication were twice more likely to be non-adherent to treatment than other patients. We surmise that probably these patients use complementary and alternative medicine (CAM) which is defined as a "group of diverse medical and healthcare systems, practices, and products that are not presently considered to be part of conventional medicine" \[[@CR31]\]. Previous studies reported an association between the use of CAM and treatment adherence and blood pressure control \[[@CR32]--[@CR35]\]. It is also reported that the experience of side effects is among the main predictors of CAM use. In this study, patients experiencing side effects were more non-adherent than their strong hypothesis of the use of CAM. Unfortunately, the use of CAM was not measured in this study, future studies may be carried out to assess the use of CAM in hypertensive patients in Kinshasa.

Unavailability of antihypertensive medication in healthcare facilities is a barrier to health care and is described as a factor of medication non-adherence. Patients who reported the availability of antihypertensive medication in healthcare facilities were about twice more likely to be adherent. These findings are consistent with that previously reported by Ghozzi in Tunis \[[@CR36]\].

We acknowledge some limitations in this study. A potential selection bias may have been introduced in this study relating to the level of care facilities surveyed. Also, information bias was possible---firstly by using the self-reported questionnaire for measuring medication adherence and secondly by reporting the blood pressure measured by non standardized methods. However, these overall findings corroborate those found in previous studies. We think that the results of this study may be generalized to hypertensive patients living in Kinshasa.

Conclusion {#Sec16}
==========

This is the first study in the DRC with a large sample to measure the antihypertensive non-adherence and to identify related predictors. These findings show that all predictors identified were modifiable by strengthening the capacity of healthcare providers by communication with patients. Antihypertensive medication should be made available in healthcare facilities.
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